Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05972291 · ClinicalTrials.gov registry record · NA
Mechanisms of Gulf War Illness
A NA study of Irritable Bowel Syndrome and Gulf War Illness, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05972291 is a NA study of Irritable Bowel Syndrome and Gulf War Illness that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 80 participants, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05972291, a NA study of Irritable Bowel Syndrome and Gulf War Illness, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Many veterans with Gulf War Illness developed chronic gastrointestinal symptoms during their deployment to the Persian Gulf. The pathophysiologic mechanisms of these chronic gastrointestinal symptoms are not well understood but cause significant morbidity in veterans. Our proposed studies will provide an innovative and novel treatment trial for chronic gastrointestinal symptoms in veterans with Gulf War Illness that were deployed into war zones. Given that there are currently no specific treatments for these disorders, and that current symptomatic approaches are far from ideal, proof of principle of our trial would be an extremely important advance as it would not only have a beneficial impact on the health of many thousands of our veterans, but also it would substantially reduce the many negative economic effects of this ailment on the VA Health Care System.
Conditions Studied
Interventions
- OTHER Control Arm
- DIETARY_SUPPLEMENT Oral Glutamine
Study Locations (1)
Tennessee
- Memphis VA Medical Center, Memphis, TN - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05972291
The ClinicalTrials.gov registry entry for NCT05972291 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (44% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Control Arm is the first listed.
NCT05972291 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05972291 about?
NCT05972291 is a clinical study titled "Mechanisms of Gulf War Illness". Many veterans with Gulf War Illness developed chronic gastrointestinal symptoms during their deployment to the Persian Gulf. The pathophysiologic mechanisms of these chronic gastrointestinal symptoms are not well understood but cause significant morbidity in veterans. Our proposed studies will provi...
What is the current status of trial NCT05972291?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-10-16. Estimated completion is 2027-07-31.
What conditions does trial NCT05972291 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome, Gulf War Illness, Gastrointestinal Symptoms.
What interventions are being tested in trial NCT05972291?
The interventions under investigation include: Control Arm (OTHER), Oral Glutamine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05972291?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05972291 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
GI Alpha-Gal Study
RECRUITING · NA
-
Visible Abdominal Distension
RECRUITING · NA
-
IBS Skin Patch Test Food Allergy Study
RECRUITING · NA
-
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
RECRUITING · NA
-
Well-being in IBS: Strengths and Happiness (WISH) 2.0
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.